Cognito Therapeutics today announced treatment results from an open-label extension study of its Alzheimer’s treating neuromodulation system. The Cambridge, Massachusetts-based company’s Spectris system could provide disease-modifying therapy for treating Alzheimer’s disease. Its non-invasive neuromodulation device delivers proprietary gamma frequency light and sound stimulation. This evokes EEG-confirmed gamma frequency brain oscillations to treat central nervous system […]
Cognito Therapeutics
Cognito Therapeutics enrolls first patient in sensory neurostim biomarker study
Cognito Therapeutics announced today that it enrolled the first patient in a biomarker study within its HOPE pivotal trial. HOPE evaluates a novel disease-modifying therapy that elicits gamma-frequency brain activity through non-invasive sensory stimulation. Cambridge, Massachusetts-based Cognito aims to slow the progression of Alzheimer’s disease from the comfort of a patient’s home. This evaluation looks […]
Cognito Therapeutics reports non-invasive neuromod data for treating Alzheimer’s
Cognito Therapeutics today announced the publication of MRI imaging data from a study of its non-invasive neurostimulation technology. The company published MRI imaging data from the Phase 2 OVERTURE study in the Journal of Alzheimer’s Disease. Cambridge, Massachusetts-based Cognito evaluated patients with mild-moderate Alzheimer’s disease receiving one-hour daily treatment. Patients underwent treatment with the Cognito gamma […]
Neuromod tech developer Cognito Therapeutics has a new CCO
Cognito Therapeutics announced today that it named Christian Howell as its new chief commercial officer (CCO). Cambridge, Massachusetts–based Cognito Therapeutics develops a non-invasive neuromodulation device that delivers proprietary gamma frequency light and sound stimulation. The company’s investigational device is intended to treat Alzheimer’s disease. Howell joins the company with more than 20 years of medical […]
Cognito Therapeutics raises $73M for non-invasive neuromod tech
Cognito Therapeutics announced today that it raised $73 million in a Series B financing round to support its neuromodulation technology. Cambridge, Massachusetts–based Cognito Therapeutics develops its neurotechnology to treat central nervous system (CNS) diseases. It designed its non-invasive neuromodulation device to deliver proprietary gamma frequency light and sound stimulation. The investigational device is intended to […]
7 digital health startups you need to watch in 2021
Digital health has skyrocketed in recent years. The pandemic has only propelled its growth by keeping patients away from doctors’ offices in droves. Thanks to the continued adoption of smartphones, the growth of connected medical devices and changes in patients’ and providers’ preferences, digital health will only continue to expand through the 2020s and beyond, […]